Tau pathology in Alzheimer disease and other tauopathies

Iqbal, Khalid, del C. Alonso, Alejandra, Chen, She, Chohan, M. Omar, El-Akkad, Ezzat, Gong, Cheng-Xin, Khatoon, Sabiha, Li, Bin +4 more·2005·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

DOI 10.1016/j.bbadis.2004.09.008

Cited by (999)

Items 101–200 of 999

Metal ions and oxidative protein modification in neurological disease.
Lawrence M. Sayre, Paula Isabel Moreira, Mark A. Smith, George L. Perry · 2005 · PubMed
The influence of phospho-tau on dendritic spines of cortical pyramidal neurons in patients with Alzheimer’s disease
Merino-Serrais, Paula, Benavides-Piccione, Ruth, Blazquez-Llorca, Lidia, Kastanauskaite, Asta, Rábano, Alberto, Avila, Jesús, DeFelipe, Javier · 2013 · Brain
Phosphorylation in the amino terminus of tau prevents inhibition of anterograde axonal transport
Kanaan, Nicholas M., Morfini, Gerardo, Pigino, Gustavo, LaPointe, Nichole E., Andreadis, Athena, Song, Yuyu, Leitman, Ellen, Binder, Lester I., Brady, Scott T. · 2012 · Neurobiology of Aging
Autophagy Dysfunction in Alzheimer’s Disease: Mechanistic Insights and New Therapeutic Opportunities
Di Meco, Antonio, Curtis, Mary Elizabeth, Lauretti, Elisabetta, Praticò, Domenico · 2020 · Biological Psychiatry
A Role for Calcineurin in Alzheimers Disease
Lindsay C. Reese, Giulio Taglialatela · 2011 · Current Neuropharmacology
Cyclooxygenase‐1 inhibition reduces amyloid pathology and improves memory deficits in a mouse model of Alzheimer's disease
Sangho Choi, Saba Aïd, Luca Caracciolo, Sakura Minami, Takako Niikura, Yasuji Matsuoka, Raymond Scott Turner, Mark P. Mattson, Francesca Bosetti · 2012 · Journal of Neurochemistry
Formaldehyde induces hyperphosphorylation and polymerization of Tau protein both in vitro and in vivo
Jing Lü, Jun-Ye MIAO, Tao Su, Ying Liu, Rongqiao He · 2013 · Biochimica et Biophysica Acta (BBA) - General Subjects
Efficacy of small‐molecule glycogen synthase kinase‐3 inhibitors in the postnatal rat model of tau hyperphosphorylation
M. L. Selenica, H S Jensen, Anna Kirstine Larsen, Mette Lund Pedersen, Lone Helboe, Marcel Leist, Julie Lotharius · 2007 · British Journal of Pharmacology
Neurotheranostics as Personalized Medicines
Kevadiya, Bhavesh D., Ottemann, Brendan M., Thomas, Midhun Ben, Mukadam, Insiya, Nigam, Saumya, McMillan, JoEllyn, Gorantla, Santhi, Bronich, Tatiana K., Edagwa, Benson, Gendelman, Howard E. · 2019 · Advanced Drug Delivery Reviews
3-Hydroxybutyrate methyl ester as a potential drug against Alzheimer's disease via mitochondria protection mechanism
Junyu Zhang, Qian Cao, Shaowu Li, Xiaoyun Lu, Yongxi Zhao, Ji‐Song Guan, Jinchun Chen, Qiong Wu, Guo‐Qiang Chen · 2013 · Biomaterials
NO synthase 2 ( <i>NOS2</i> ) deletion promotes multiple pathologies in a mouse model of Alzheimer's disease
Colton, C. A., Vitek, M. P., Wink, D. A., Xu, Q., Cantillana, V., Previti, M. L., Van Nostrand, W. E., Weinberg, J. B., Dawson, H. · 2006 · Proceedings of the National Academy of Sciences
Pathological Tau From Alzheimer’s Brain Induces Site-Specific Hyperphosphorylation and SDS- and Reducing Agent-Resistant Aggregation of Tau in vivo
Jin Miao, Ruirui Shi, Longfei Li, Feng Chen, Yan Zhou, Yunn Chyn Tung, Wen Hui Hu, Cheng‐Xin Gong, Khalid Iqbal, Fei Liu · 2019 · Frontiers in Aging Neuroscience
Cdk5: Multitasking between physiological and pathological conditions
João Pedro Lopes, Paula M. Agostinho · 2011 · Progress in Neurobiology
Microglia-derived extracellular vesicles in Alzheimer’s Disease: A double-edged sword
Trotta, Teresa, Antonietta Panaro, Maria, Cianciulli, Antonia, Mori, Giorgio, Di Benedetto, Adriana, Porro, Chiara · 2018 · Biochemical Pharmacology
Sex difference in pathology and memory decline in rTg4510 mouse model of tauopathy
Mei Yue, Amanda Hanna, Judith Wilson, Hanno M. Roder, Christopher Janus · 2009 · Neurobiology of Aging
The Gut-Microglia Connection: Implications for Central Nervous System Diseases
Yiliang Wang, Zhaoyang Wang, Yun Wang, Feng Li, Jiaoyan Jia, Xiaowei Song, Shurong Qin, Rongze Wang, Fujun Jin, Kaio Kitazato et al. · 2018 · Frontiers in Immunology
Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease?
Christian Humpel · 2010 · Experimental Gerontology
Magnetic Resonance Spectroscopy in Alzheimer’s Disease: Systematic Review and Meta-Analysis
Wang, Hui, Tan, Lan, Wang, Hui-Fu, Liu, Ying, Yin, Rui-Hua, Wang, Wen-Ying, Chang, Xiao-Long, Jiang, Teng, Yu, Jin-Tai · 2015 · Journal of Alzheimer’s Disease
Small-molecule PET Tracers for Imaging Proteinopathies
Chester A. Mathis, Brian J. Lopresti, Miloš D. Ikonomović, William Edward Klunk · 2017 · Seminars in Nuclear Medicine
Advanced Glycation End Products Modulate Amyloidogenic APP Processing and Tau Phosphorylation: A Mechanistic Link between Glycation and the Development of Alzheimer’s Disease
Kedar Batkulwar, Rashmi K. Godbole, Reema Banarjee, Omar Kassaar, Robert J. Williams, Mahesh J. Kulkarni · 2018 · ACS Chemical Neuroscience
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum
Isabelle Bos, Stephanie J. B. Vos, Frans R.J. Verhey, Philip Scheltens, Charlotte Elisabeth Teunissen, Sebastiaan Engelborghs, Kristel Sleegers, Giovanni Battista Frisoni, Olivier J. Blin, Jill C. Richardson et al. · 2019 · Alzheimer s & Dementia
Implications of Glycosylation in Alzheimer’s Disease
Haukedal, Henriette, Freude, Kristine K. · 2021 · Frontiers in Neuroscience
Diabetes Mellitus Induces Alzheimer’s Disease Pathology: Histopathological Evidence from Animal Models
Nobuyuki Kimura · 2016 · International Journal of Molecular Sciences
Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer’s disease
Syed Faraz Kazim, Khalid Iqbal · 2016 · Molecular Neurodegeneration
NMDA Receptor Antagonists: Repositioning of Memantine as a Multitargeting Agent for Alzheimer's Therapy
Md. Tanvir Kabir, Mohammad Abu Sufian, Md. Sahab Uddin, Mst. Marium Begum, Shammi Akhter, Ariful Islam, Bijo Mathew, Md. Siddiqul Islam, Md. Shah Amran, Ghulam Md Ashraf · 2019 · Current Pharmaceutical Design
Insulin Resistance Exacerbates Alzheimer Disease via Multiple Mechanisms
Zeng-Hui Wei, Jagadish Koya, Sandra E. Reznik · 2021 · Frontiers in Neuroscience
Zinc Binding Directly Regulates Tau Toxicity Independent of Tau Hyperphosphorylation
Yunpeng Huang, Zhihao Wu, Yu Cao, Minglin Lang, Bingwei Lu, Bing Zhou · 2014 · Cell Reports
Phosphorylation of tau at Ser214 mediates its interaction with 14‐3‐3 protein: implications for the mechanism of tau aggregation
Golam Sadik, Toshihisa Tanaka, Kiyoko Kato, Hidenaga Yamamori, Nurun N. Begum, Takashi Morihara, Masatoshi Takeda · 2008 · Journal of Neurochemistry
Functional genomic screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylation
Ambegaokar, Surendra S., Jackson, George R. · 2011 · Human Molecular Genetics
BACE1 in Alzheimer's disease
M. Sathya, Premkumar Palanisamy, Karthick Chennakesavan, Moorthi Ponnusamy, Kesavan Swaminathan Jayachandran, Muthuswamy Anusuyadevi · 2012 · Clinica Chimica Acta
Genome wide profiling of altered gene expression in the neocortex of Alzheimer's disease
Michelle G. Tan, Wei T Chua, Margaret M. Esiri, A. David Smith, Harry V. Vinters, Mitchell K.P. Lai · 2009 · Journal of Neuroscience Research
Recent therapeutic strategies targeting beta amyloid and tauopathies in Alzheimer's disease
Yamini Madav, Sarika Wairkar, Bala R. Prabhakar · 2019 · Brain Research Bulletin
Role of miRNAs in Alzheimer’s Disease and Possible Fields of Application
Serena Silvestro, Placido Bramanti, Emanuela Mazzon · 2019 · International Journal of Molecular Sciences
Alzheimer disease therapeutics: Focus on the disease and not just plaques and tangles
Khalid Iqbal, Fei Liu, Cheng‐Xin Gong · 2014 · Biochemical Pharmacology
On the Molecular Basis Linking Nerve Growth Factor (NGF) to Alzheimer’s Disease
Simona Capsoni, Antonino Cattaneo · 2006 · Cellular and Molecular Neurobiology
Protein Phosphatases and Alzheimer's Disease
Steven P. Braithwaite, Jeffry B. Stock, Paul J. Lombroso, Angus Clark Nairn · 2012 · Progress in molecular biology and translational science
Diabetes as a risk factor for Alzheimer’s disease in the Middle East and its shared pathological mediators
Richard L. Jayaraj, Sheikh Azimullah, Rami Beiram · 2019 · Saudi Journal of Biological Sciences
Physical Exercise and Brain Mitochondrial Fitness: The Possible Role Against <scp>A</scp>lzheimer's Disease
Bernardo, T.C., Marques‐Aleixo, I., Beleza, J., Oliveira, P.J., Ascensão, A., Magalhães, J. · 2016 · Brain Pathology
Cerebral Small Vessel Disease and Alzheimer's Disease: A Review
Hae Won Kim, Jeong‐Ho Hong, Jae Cheon Jeon · 2020 · Frontiers in Neurology
NMNAT suppresses Tau-induced neurodegeneration by promoting clearance of hyperphosphorylated Tau oligomers in a Drosophila model of tauopathy
Yousuf Ali, Kai Ruan, Rong Grace Zhai · 2011 · Human Molecular Genetics
Alzheimer’s Disease: Mechanism and Approach to Cell Therapy
Takashi Amemori, Pavla Jendelová, Jiří Růžička, Lucia Machová Urdzíková, Eva Syková · 2015 · International Journal of Molecular Sciences
Recent advancements in the field of nanotechnology for the delivery of anti-Alzheimer drug in the brain region
Mukta Agrawal, Swarnlata Saraf, Shailendra Saraf, Sophia G. Antimisiaris, Nobuhito Hamano, Shyh‐Dar Li, Mahavir Bhupal Chougule, Sunday Shoyele, Umesh Dutta Gupta, M. Ajazuddin et al. · 2018 · Expert Opinion on Drug Delivery
The microbiota–microglia axis in central nervous system disorders
Mossad, Omar, Erny, Daniel · 2020 · Brain Pathology
Link Between DYRK1A Overexpression and Several-Fold Enhancement of Neurofibrillary Degeneration With 3-Repeat Tau Protein in Down Syndrome
Jerzy Węgiel, Wojciech Kaczmarski, Madhabi Barua, Izabela Kuchna, Krzysztof Nowicki, Kuo-Chiang Wang, Jarek Wegiel, Bozena Mazur‐Kolecka, Janusz Frackowiak, Bozena Mazur‐Kolecka et al. · 2010 · Journal of Neuropathology & Experimental Neurology
Microtubule-associated protein 1B, a growth-associated and phosphorylated scaffold protein
Beat Michel Riederer · 2006 · Brain Research Bulletin
Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
Mroczko, Barbara, Groblewska, Magdalena, Litman-Zawadzka, Ala, Kornhuber, Johannes, Lewczuk, Piotr · 2018 · International Journal of Molecular Sciences
Direct Comparison of the Tau PET Tracers18F-Flortaucipir and18F-MK-6240 in Human Subjects
Alexandra Gogola, Davneet Singh Minhas, Victor L. Villemagne, Ann D. Cohen, James M. Mountz, Tharick Ali Pascoal, Charles M. Laymon, Neale Scott Mason, Miloš D. Ikonomović, Chester A. Mathis et al. · 2021 · Journal of Nuclear Medicine
Alois Alzheimer and Alzheimer's disease: a centennial perspective
David Henry Small, Roberto Cappai · 2006 · Journal of Neurochemistry
The Effects of NOS2 Gene Deletion on Mice Expressing Mutated Human AβPP
Carol A. Colton, Donna M. Wilcock, David A. Wink, Judianne Davis, William E. Van Nostrand, Michael Peter Vitek · 2008 · Journal of Alzheimer s Disease
The effect of chronic cerebral hypoperfusion on the pathology of Alzheimer's disease: A positron emission tomography study in rats
Jae‐Hyung Park, Jeong‐Ho Hong, Sang‐Woo Lee, Hyun Dong Ji, Jung-Ah Jung, Kyung-Wha Yoon, Jung-In Lee, Kyoung Sook Won, Bong‐Il Song, Hae Won Kim · 2019 · Scientific Reports
Beta Amyloid, Tau Protein, and Neuroinflammation: An Attempt to Integrate Different Hypotheses of Alzheimer’s Disease Pathogenesis
David G. Garbuz, Olga G. Zatsepina, Michael B. Evgen’ev · 2021 · Molecular Biology
Microtubule lattice spacing governs cohesive envelope formation of tau family proteins
Siahaan, Valerie, Tan, Ruensern, Humhalova, Tereza, Libusova, Lenka, Lacey, Samuel E., Tan, Tracy, Dacy, Mariah, Ori-McKenney, Kassandra M., McKenney, Richard J., Braun, Marcus et al. · 2022 · Nature Chemical Biology
A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics
Hanna Rosenmann, Nikolaos Grigoriadis, Hila Eldar-Levy, Avi Avital, Lea Rozenstein‐Tsalkovich, Olga Touloumi, Leah Behar, Tamir Ben‐Hur, Yosefa Avraham, Eliot Berry et al. · 2008 · Experimental Neurology
Extracellular association of APP and tau fibrils induces intracellular aggregate formation of tau
Muneaki Takahashi, Haruka Miyata, Fuyuki Kametani, Takashi Nonaka, Haruhiko Akiyama, Shin‐ichi Hisanaga, Masato Hasegawa · 2015 · Acta Neuropathologica
Resveratrol Attenuates Formaldehyde Induced Hyperphosphorylation of Tau Protein and Cytotoxicity in N2a Cells
Xiaping He, Zhenhui Li, Joshua D. Rizak, Shihao Wu, Zhengbo Wang, Rongqiao He, Min Su, Dongdong Qin, Jingkun Wang, Xintian Hu · 2017 · Frontiers in Neuroscience
Development of novel phosphodiesterase 5 inhibitors for the therapy of Alzheimer’s disease
Elisa Zuccarello, Erica Acquarone, Elisa Calcagno, Elentina K. Argyrousi, Shi‐Xian Deng, Donald W. Landry, Ottavio Arancio, Jole Fiorito · 2020 · Biochemical Pharmacology
PET and SPECT Imaging in Psychiatric Disorders
Robert B. Zipursky, Jeffrey H. Meyer, Nicolaas Paul L.G. Verhoeff · 2007 · The Canadian Journal of Psychiatry
Infectious origin of Alzheimer’s disease: Amyloid beta as a component of brain antimicrobial immunity
Vojtechova, Iveta, Machacek, Tomas, Kristofikova, Zdenka, Stuchlik, Ales, Petrasek, Tomas · 2022 · PLOS Pathogens
Redox Control of Neural Function: Background, Mechanisms, and Significance
P. Maher · 2006 · Antioxidants and Redox Signaling
Alkaline Phosphatase Is Increased in both Brain and Plasma in Alzheimer’s Disease
Emma R. L. C. Vardy, Katherine A. B. Kellett, Sarah L. Cocklin, Nigel M. Hooper · 2011 · Neurodegenerative Diseases
Calcium channelopathies and Alzheimer's disease: Insight into therapeutic success and failures
Chakroborty, Shreaya, Stutzmann, Grace E. · 2014 · European Journal of Pharmacology
Blood–Brain Barrier and Neurodegenerative Diseases—Modeling with iPSC-Derived Brain Cells
Ying‐Chieh Wu, Tuuli-Maria Sonninen, Sanni Peltonen, Jari Koıstınaho, Šárka Lehtonen · 2021 · International Journal of Molecular Sciences
Anti-Neuroinflammatory Property of Phlorotannins from Ecklonia cava on Aβ25-35-Induced Damage in PC12 Cells
Seung‐Eun Lee, Kumju Youn, Dong Hyun Kim, Mok‐Ryeon Ahn, Eunju Yoon, Oh Yoen Kim, Mira Jun · 2018 · Marine Drugs
Phosphoproteomic Analysis of Human Brain by Calcium Phosphate Precipitation and Mass Spectrometry
Qiangwei Xia, Dongmei Cheng, Duc Minh Duong, Marla Gearing, James J. Lah, Allan I. Levey, Junmin Peng · 2008 · Journal of Proteome Research
Tau protein abnormalities associated with the progression of alzheimer disease type dementia
Haroutunian, V., Davies, P., Vianna, C., Buxbaum, J.D., Purohit, D.P. · 2007 · Neurobiology of Aging
Development of Near-Infrared Fluorescent Probes for Use in Alzheimer’s Disease Diagnosis
Jian Yang, Fantian Zeng, Yiran Ge, Kewen Peng, Xiaofang Li, Yuyan Li, Yungen Xu · 2019 · Bioconjugate Chemistry
Peroxynitrite induces Alzheimer‐like tau modifications and accumulation in rat brain and its underlying mechanisms
Yongjie Zhang, Yafei Xu, Yinghua Liu, Jun Yin, Honglian Li, Qun Wang, Jian‐Zhi Wang · 2006 · The FASEB Journal
The role of glycogen synthase kinase 3 in the early stages of Alzheimers’ disease
Félix Hernández, Jesús Ávila · 2008 · FEBS Letters
The Gonadotropin Connection in Alzheimer's Disease
Sivan Vadakkadath Meethal, Mark A. Smith, Richard L. Bowen, Craig Atwood · 2005 · Endocrine
Suppression of Cyclin-Dependent Kinase 5 Activation by Amyloid Precursor Protein: A Novel Excitoprotective Mechanism Involving Modulation of Tau Phosphorylation
Ping Han, Fei Dou, Feng Li, Xue Zhang, Yun‐wu Zhang, Hui Zheng, Stuart A. Lipton, Huaxi Xu, Francesca‐Fang Liao · 2005 · Journal of Neuroscience
Brain site‐specific gene expression analysis in Alzheimer's disease patients
T. Yokota, Manisha Mishra, Hiroyasu Akatsu, Y. Tani, T. Miyauchi, Takayuki Yamamoto, Kenji Kosaka, Y. Nagai, Tohru Sawada, Klaus Heese · 2006 · European Journal of Clinical Investigation
Obesity, diabetes, and leptin resistance promote tau pathology in a mouse model of disease
Thomas L Platt, Tina L. Beckett, Katharina Köhler, Dana M. Niedowicz, M.P. Murphy · 2015 · Neuroscience
ECM in brain aging and dementia
Morawski, Markus, Filippov, Mikhail, Tzinia, Athina, Tsilibary, Effie, Vargova, Lydia · 2014 · Progress in Brain Research
I PP2A 1 Affects Tau Phosphorylation via Association with the Catalytic Subunit of Protein Phosphatase 2A
She Chen, Bin Li, Inge Grundke, Khalid Iqbal · 2008 · Journal of Biological Chemistry
Multi-Target Drug Candidates for Multifactorial Alzheimer’s Disease: AChE and NMDAR as Molecular Targets
Uddin, Md. Sahab, Al Mamun, Abdullah, Kabir, Md. Tanvir, Ashraf, Ghulam Md, Bin-Jumah, May N., Abdel-Daim, Mohamed M. · 2021 · Molecular Neurobiology
Neuronal protein trafficking associated with Alzheimer disease
Bor Luen Tang · 2009 · Cell Adhesion & Migration
Tau aggregation and progressive neuronal degeneration in the absence of changes in spine density and morphology after targeted expression of Alzheimer's disease-relevant tau constructs in organotypic hippocampal slices
Shahani, Neelam, Subramaniam, Srinivasa, Wolf, Tobias, Tackenberg, Christian, Brandt, Roland · 2006 · The Journal of Neuroscience
Expression of a truncated tau protein induces oxidative stress in a rodent model of tauopathy
Cente, Martin, Filipcik, Peter, Pevalova, Miroslava, Novak, Michal · 2006 · European Journal of Neuroscience
Quantitative Analysis of the Brain Ubiquitylome in Alzheimer's Disease
Measho H. Abreha, Eric B. Dammer, Lingyan Ping, Tian Zhang, Duc Minh Duong, Marla Gearing, James J. Lah, Allan I. Levey, Nicholas T. Seyfried · 2018 · PROTEOMICS
Lactobacillus plantarum DP189 prevents cognitive dysfunction in D-galactose/AlCl 3 induced mouse model of Alzheimer’s disease via modulating gut microbiota and PI3K/Akt/GSK-3β signaling pathway
Xinping Song, Zijian Zhao, Yujuan Zhao, Zhiguo Wang, Chao Wang, Ge Yang, Shengyu Li · 2021 · Nutritional Neuroscience
Hypoxia Increases Aβ-Induced Tau Phosphorylation by Calpain and Promotes Behavioral Consequences in AD Transgenic Mice
Lianbo Gao, Shen Tian, Hong-Hua Gao, Yan-Yuan Xu · 2013 · Journal of Molecular Neuroscience
Biallelic Mutations in TBCD , Encoding the Tubulin Folding Cofactor D, Perturb Microtubule Dynamics and Cause Early-Onset Encephalopathy
Elisabetta Flex, Marcello Niceta, Serena Cecchetti, Isabelle Thiffault, Margaret Au, Alessandro Capuano, Emanuela Piermarini, Anna Ivanova, Joshua W. Francis, Giovanni Chillemi et al. · 2016 · The American Journal of Human Genetics
Antibody-Mediated Clearance of Brain Amyloid-β: Mechanisms of Action, Effects of Natural and Monoclonal Anti-Aβ Antibodies, and Downstream Effects
David A. Loeffler · 2023 · Journal of Alzheimer s Disease Reports
Regulation between O‐GlcNAcylation and phosphorylation of neurofilament‐M and their dysregulation in Alzheimer disease
Yanqiu Deng, Bin Li, Fei Liu, Khalid Iqbal, Inge Grundke, Roland Brandt, Cheng‐Xin Gong · 2007 · The FASEB Journal
Amyloid-β and Astrocytes Interplay in Amyloid-β Related Disorders
Yazan S. Batarseh, Quoc-Viet Duong, Youssef M. Mousa, Sweilem B. Al Rihani, Khaled H. Elfakhri, Amal Kaddoumi · 2016 · International Journal of Molecular Sciences
(−)-P7C3-S243 Protects a Rat Model of Alzheimer’s Disease From Neuropsychiatric Deficits and Neurodegeneration Without Altering Amyloid Deposition or Reactive Glia
Voorhees, Jaymie R., Remy, Matthew T., Cintrón-Pérez, Coral J., El Rassi, Eli, Khan, Michael Z., Dutca, Laura M., Yin, Terry C., McDaniel, Latisha N., Williams, Noelle S., Brat, Daniel J. et al. · 2018 · Biological Psychiatry
Aqueous extract of lavender (Lavandula angustifolia) improves the spatial performance of a rat model of Alzheimer’s disease
Masoud Soheili Kashani, Mostafa Rezaei–Tavirani, Sayyed Alireza Talaei, Mahmoud Salami · 2011 · Neuroscience Bulletin
Amyloid-β and Phosphorylated Tau are the Key Biomarkers and Predictors of Alzheimer’s Disease
Jangampalli Adi Pradeepkiran, Javaria Baig, Md Ariful Islam, Sudhir Kshirsagar, P. Hemachandra Reddy · 2024 · Aging and Disease
Dysregulation of Protein Phosphorylation/Dephosphorylation in Alzheimer′s Disease: A Therapeutic Target
Cheng‐Xin Gong, Fei Liu, Inge Grundke, Khalid Iqbal · 2006 · BioMed Research International
Tau-mediated Neurodegeneration and Potential Implications in Diagnosis and Treatment of Alzheimer's Disease
Xilin Wu, Juan Piña-Crespo, Yun‐wu Zhang, Xiaochun Chen, Huaxi Xu · 2017 · Chinese Medical Journal
High cholesterol diet induces tau hyperphosphorylation in apolipoprotein E deficient mice
Atiqur Rahman, Susanne Akterin, Amilcar Flores‐Morales, Milita Crisby, Miia Kivipelto, Marianne Schultzberg, Ángel Cedazo-Mı́nguez · 2005 · FEBS Letters
Can dendrimer based nanoparticles fight neurodegenerative diseases? Current situation versus other established approaches
Serge M. Mignani, Maria J Bryszewska, Maria Zabłocka, Barbara Klajnert‐Maculewicz, Josep Cladera, Dzmitry Shcharbin, Jean‐Pierre Majoral · 2016 · Progress in Polymer Science
The modulation of metal bio‐availability as a therapeutic strategy for the treatment of Alzheimer's disease
P. Crouch, A. White, A. I. Bush · 2007 · The FEBS Journal
Autoimmune and inflammatory mechanisms of CNS damage
Minesh Kapadia, Boris Šakić · 2011 · Progress in Neurobiology
Microtubule-associated protein tau as a therapeutic target in Alzheimer's disease
Khalid Iqbal, Cheng‐Xin Gong, Fei Liu · 2014 · Expert Opinion on Therapeutic Targets
Impulse noise exposure in rats causes cognitive deficits and changes in hippocampal neurotransmitter signaling and tau phosphorylation
Bo Cui, Mingquan Wu, Xiaojun She, Hongtao Liu · 2011 · Brain Research
RETRACTED: Mitophagy enhancers against phosphorylated Tau-induced mitochondrial and synaptic toxicities in Alzheimer disease
Sudhir Kshirsagar, Neha A. Sawant, Hallie Morton, Arubala P. Reddy, P. Hemachandra Reddy · 2021 · Pharmacological Research · Retracted
Phosphoproteomic Analysis Reveals Site-Specific Changes in GFAP and NDRG2 Phosphorylation in Frontotemporal Lobar Degeneration
Jeremy H. Herskowitz, Nicholas T. Seyfried, Duc Minh Duong, Qiangwei Xia, Howard D. Rees, Marla Gearing, Junmin Peng, James J. Lah, Allan I. Levey · 2010 · Journal of Proteome Research
Immune-Inflammatory Responses and Oxidative Stress in Alzheimers Disease: Therapeutic Implications
Danilo Di Bona, Giovanni Scapagnini, Giuseppina Candore, Laura Castiglia, Giuseppina Colonna‐Romano, Giovanni Duro, Domenico Nuzzo, Francesco Iemolo, Domenico Lio, Mariavaleria Pellicanò et al. · 2010 · Current Pharmaceutical Design
Accumulation of tumor-suppressor PTEN in Alzheimer neurofibrillary tangles
Sonoda, Yuma, Mukai, Hideyuki, Matsuo, Kazuhiko, Takahashi, Mikiko, Ono, Yoshitaka, Maeda, Kiyoshi, Akiyama, Haruhiko, Kawamata, Toshio · 2010 · Neuroscience Letters